CSL Ltd (CSL) - Financial and Strategic SWOT Analysis Review

CSL Ltd (CSL) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

CSL Ltd (CSL) is a biotechnology company. It discovers, develops, manufactures, commercializes and distributes biopharmaceuticals. The company's product portfolio comprises treatments for hemophilia and immune deficiencies, vaccines to prevent influenza and therapies for iron deficiency and kidney conditions. CSL focuses on therapeutic areas including hematology, respiratory, cardiovascular and metabolic, nephrology and transplant, immunology and vaccines. The company operates in various countries including Australia, China, Germany, Switzerland, the US, Hungary, Puerto Rico, the UK, Italy, Japan, Netherlands and Spain. CSL is headquartered in Melbourne, Victoria, Australia.

CSL Ltd Key Recent Developments

Aug 13,2024: CSL Appoints Elaine Sorg as Independent Non-Executive Director
Jun 03,2024: CSL Global Headquarters/Elizabeth North Stage 2 Melbourne, Victoria
May 31,2024: CSL Seqirus to make bird flu vaccine in Holly Springs
Apr 17,2024: Mini brains and lab-on-a-chip wearables: Jumar Bioincubator officially begins its mission to build “Australia’s next CSL”

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
CSL Ltd - Key Facts
CSL Ltd - Key Employees
CSL Ltd - Key Employee Biographies
CSL Ltd - Major Products and Services
CSL Ltd - History
CSL Ltd - Company Statement
CSL Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
CSL Ltd - Business Description
Business Segment: CSL Behring
Overview
Performance
Business Segment: CSL Seqirus
Overview
Performance
Business Segment: CSL Vifor
Overview
Performance
Geographical Segment: Australia
Performance
Geographical Segment: China and Hong Kong
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: Switzerland
Performance
Geographical Segment: UK
Performance
Geographical Segment: United States
Performance
R&D Overview
CSL Ltd - Corporate Strategy
CSL Ltd - SWOT Analysis
SWOT Analysis - Overview
CSL Ltd - Strengths
CSL Ltd - Weaknesses
CSL Ltd - Opportunities
CSL Ltd - Threats
CSL Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
CSL Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
CSL Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
CSL Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 13, 2024: CSL Appoints Elaine Sorg as Independent Non-Executive Director
Jun 03, 2024: CSL Global Headquarters/Elizabeth North Stage 2 Melbourne, Victoria
May 31, 2024: CSL Seqirus to make bird flu vaccine in Holly Springs
Apr 17, 2024: Mini brains and lab-on-a-chip wearables: Jumar Bioincubator officially begins its mission to build “Australia’s next CSL”
Mar 06, 2024: CSL Seqirus is Fully Prepared to Implement the FDA's Vaccines and Related Biological Products Advisory Committee Trivalent Influenza Vaccines Strain Selection for the 2024/25 U.S. Season
Feb 12, 2024: Half year reported NPATA US$2 billion, Up 13% at constant currency
Dec 12, 2023: CSL Behring Is Illinois Manufacturer of the Year
Oct 12, 2023: CSL Signs Renewable-Linked Power Purchase Agreement with AGL to Supply Electricity to Australian Manufacturing Sites
Sep 19, 2023: CSL Seqirus Presents Real-World Evidence at ESWI Demonstrating the Impact of Influenza Vaccination Campaigns to Help Protect People and Healthcare Systems
Aug 28, 2023: CSL Seqirus Announces Third U.S. Government Award in Relation to Influenza A(H5N8) Candidate Vaccine
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
CSL Ltd, Key Facts
CSL Ltd, Key Employees
CSL Ltd, Key Employee Biographies
CSL Ltd, Major Products and Services
CSL Ltd, History
CSL Ltd, Other Locations
CSL Ltd, Subsidiaries
CSL Ltd, Key Competitors
CSL Ltd, Ratios based on current share price
CSL Ltd, Annual Ratios
CSL Ltd, Annual Ratios (Cont...1)
CSL Ltd, Annual Ratios (Cont...2)
CSL Ltd, Interim Ratios
CSL Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
CSL Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
CSL Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
CSL Ltd, Performance Chart (2020 - 2024)
CSL Ltd, Ratio Charts
CSL Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
CSL Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings